Bristol Myers Squibb is a pharmaceutical company that develops and sells branded prescription medicines. It last closed at $58.80 on Nov 20, up 0.79% on the day. The next earnings report for BMY is expected around Thu, Feb 4, 2027. For the quarter ended Sep 2026, BMY reported EPS of $1.05 on revenue of $13.07B, with revenue up 6.9% from a year ago. Over its last 8 reports the stock moved an average of 3.7% the session after earnings. Over the last 12 months BMY insiders bought $0 of stock on the open market and sold $2.5M, according to SEC Form 4 filings.
AI Auto Pilots
Is BMY in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BMY.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on BMYStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
BMY · as of the Nov 20 close · updated each morning
Turning down
The stock is 5% below its 20 day and 5% below its 50 day average. It is 3% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 39). The nearest support is the Pivot S1 at $58.39, and the nearest resistance the swing high (Jun 30) at $58.88.
Short trendBearish
Long trendNeutral
MomentumWeak
StretchNormal
VolatilityHigh, 3.0%/day
Key levels
$68.6452 week high+16.7%
$62.44100 day average+6.2%
$61.8220 day average+5.1%
$61.4550 day average+4.5%
$60.43200 day average+2.8%
$59.51Pivot R1+1.2%
$59.10Pivot+0.5%
$58.88Swing high (Jun 30)+0.1%
$58.80Last close
$58.39Pivot S1−0.7%
$58.33Swing low (Oct 5)−0.8%
$45.2752 week low−23.0%
Indicators
RSI (14)
39.45
Weak, oversold below 30
Neutral
MACD
-0.43
Below its signal line
Bearish
Stochastic
6.5
Near the bottom of its range
Oversold
ADX (14)
14.6
No clear trend
Williams %R
-88.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-163.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−5.4%
Change over 10 sessions
Bearish
ATR (14)
$1.79
Typical daily range, 3.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Moving sideways
Short trendNeutral
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 6.5%/day
Key levels
$68.6452 week high+16.7%
$62.44100 day average+6.2%
$61.8220 day average+5.1%
$61.4550 day average+4.5%
$60.43200 day average+2.8%
$59.51Pivot R1+1.2%
$59.10Pivot+0.5%
$58.88Swing high (Jun 30)+0.1%
$58.80Last close
$58.39Pivot S1−0.7%
$58.33Swing low (Oct 5)−0.8%
$45.2752 week low−23.0%
Indicators
RSI (14)
44.63
Middle of its range
Neutral
MACD
0.60
Below its signal line
Bearish
Stochastic
42.5
Middle of its range
Neutral
ADX (14)
20.2
Weak trend
Williams %R
-78.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
-67.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−7.6%
Change over 10 sessions
Bearish
ATR (14)
$3.80
Typical daily range, 6.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for BMY
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how BMY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow BMY usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for BMYHow many large options trades hit BMY, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in BMY in the last 90 days.
From SEC Form 4 filings by BMY's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Oct 29, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BMY is in one of them and how their past BMY trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Bristol Myers Squibb
Bristol Myers Squibb is a pharmaceutical company based in Princeton, New Jersey. It develops, produces and sells branded prescription medicines, including Eliquis, Opdivo and Orencia, and it continues to research new drugs. Its products are paid for through government programs and commercial insurance plans, so pricing and coverage rules affect its sales.